S&P 500   4,288.39 (+0.01%)
DOW   33,433.35 (-0.22%)
QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.89%)
MU   67.96 (-0.10%)
CGC   0.74 (-5.85%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.15 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
S&P 500   4,288.39 (+0.01%)
DOW   33,433.35 (-0.22%)
QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.89%)
MU   67.96 (-0.10%)
CGC   0.74 (-5.85%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.15 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
S&P 500   4,288.39 (+0.01%)
DOW   33,433.35 (-0.22%)
QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.89%)
MU   67.96 (-0.10%)
CGC   0.74 (-5.85%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.15 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
S&P 500   4,288.39 (+0.01%)
DOW   33,433.35 (-0.22%)
QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.89%)
MU   67.96 (-0.10%)
CGC   0.74 (-5.85%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.15 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
NASDAQ:EXPO

Exponent (EXPO) Stock Forecast, Price & News

$85.18
-0.42 (-0.49%)
(As of 05:19 PM ET)
Compare
Today's Range
$84.33
$85.71
50-Day Range
$85.34
$95.63
52-Week Range
$84.33
$112.75
Volume
218,557 shs
Average Volume
288,479 shs
Market Capitalization
$4.33 billion
P/E Ratio
43.24
Dividend Yield
1.22%
Price Target
$104.50

Exponent MarketRank™ Forecast

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
22.7% Upside
$104.50 Price Target
Short Interest
Bearish
2.33% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
N/A
News Sentiment
0.01mentions of Exponent in the last 14 days
Based on 7 Articles This Week
Insider Trading
Selling Shares
$176,270 Sold Last Quarter
Proj. Earnings Growth
9.27%
From $2.05 to $2.24 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.32 out of 5 stars

Business Services Sector

146th out of 316 stocks

Management Consulting Services Industry

13th out of 15 stocks


EXPO stock logo

About Exponent (NASDAQ:EXPO) Stock

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.

EXPO Price History

EXPO Stock News Headlines

Exponent: Highly Profitable Business With A Wide Moat
[BREAKING] Pentagon to Spend Billions on "Living Missile"
Air Force Magazine calls it "transformational." The Wall Street Journal calls it one of the Pentagon's "highest priorities." National Defense Magazine reports "Eye-popping budget" for it. This small company won the first contract to build them!
‘Our art forms are like rivers’
Exponent, Inc. (NASDAQ:EXPO) Goes Ex-Dividend Soon
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Here’s Why Exponent (EXPO) Declined in Q2
Q2 2023 Exponent Inc Earnings Call
Exponent Declares Quarterly Dividend for Q3 2023
EXPO - Exponent, Inc.
Exponent: High Quality At A High Price
See More Headlines
Receive EXPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exponent and its competitors with MarketBeat's FREE daily newsletter.

EXPO Company Calendar

Last Earnings
7/27/2023
Ex-Dividend for 9/22 Dividend
9/07/2023
Dividend Payable
9/22/2023
Today
10/02/2023
Next Earnings (Estimated)
10/26/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Management consulting services
Sub-Industry
Research & Consulting Services
Current Symbol
NASDAQ:EXPO
CUSIP
30214U10
Employees
1,313
Year Founded
1967

Price Target and Rating

Average Stock Price Forecast
$104.50
High Stock Price Forecast
$110.00
Low Stock Price Forecast
$99.00
Forecasted Upside/Downside
+22.7%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Net Income
$102.33 million
Pretax Margin
25.38%

Debt

Sales & Book Value

Annual Sales
$513.29 million
Cash Flow
$2.15 per share
Book Value
$6.33 per share

Miscellaneous

Free Float
49,730,000
Market Cap
$4.33 billion
Optionable
Optionable
Beta
0.62

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Dr. Catherine Ford Corrigan P.E. (Age 54)
    Ph.D., Pres, CEO & Director
    Comp: $1.79M
  • Mr. Richard L. Schlenker Jr.Mr. Richard L. Schlenker Jr. (Age 57)
    Exec. VP, CFO & Corp. Sec.
    Comp: $1.14M
  • Dr. Bernard Ross P.E.
    Ph.D., Co-Founder, Chairman Emeritus & Principal Engineer
  • Dr. Subbaiah V. Malladi P.E. (Age 76)
    Ph.D., CTO & Principal Engineer
  • Ms. Sally B. ShepardMs. Sally B. Shepard (Age 62)
    Chief HR Officer
  • Dr. Eric Guyer P.E.
    Ph.D., Group VP for US Offices & Principal Engineer
  • Mr. Eric R. Anderson
    VP & Corp. Controller
  • Joseph RakowJoseph Rakow
    Group VP
  • Mr. Richard Fioravanti
    Principal Consultant













EXPO Stock - Frequently Asked Questions

Should I buy or sell Exponent stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" EXPO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EXPO, but not buy additional shares or sell existing shares.
View EXPO analyst ratings
or view top-rated stocks.

What is Exponent's stock price forecast for 2023?

3 analysts have issued twelve-month price targets for Exponent's stock. Their EXPO share price forecasts range from $99.00 to $110.00. On average, they anticipate the company's share price to reach $104.50 in the next twelve months. This suggests a possible upside of 22.7% from the stock's current price.
View analysts price targets for EXPO
or view top-rated stocks among Wall Street analysts.

How have EXPO shares performed in 2023?

Exponent's stock was trading at $99.09 on January 1st, 2023. Since then, EXPO shares have decreased by 14.0% and is now trading at $85.18.
View the best growth stocks for 2023 here
.

Are investors shorting Exponent?

Exponent saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 1,170,000 shares, an increase of 10.4% from the August 31st total of 1,060,000 shares. Based on an average daily volume of 212,200 shares, the days-to-cover ratio is presently 5.5 days. Currently, 2.3% of the shares of the company are sold short.
View Exponent's Short Interest
.

When is Exponent's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 26th 2023.
View our EXPO earnings forecast
.

How were Exponent's earnings last quarter?

Exponent, Inc. (NASDAQ:EXPO) released its earnings results on Thursday, July, 27th. The business services provider reported $0.50 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.51 by $0.01. The business services provider earned $129.65 million during the quarter, compared to the consensus estimate of $130.40 million. Exponent had a net margin of 19.03% and a trailing twelve-month return on equity of 30.41%. The business's revenue for the quarter was up 9.7% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.49 earnings per share.

How often does Exponent pay dividends? What is the dividend yield for Exponent?

Exponent declared a quarterly dividend on Tuesday, July 25th. Investors of record on Friday, September 8th will be paid a dividend of $0.26 per share on Friday, September 22nd. This represents a $1.04 annualized dividend and a yield of 1.22%. The ex-dividend date of this dividend is Thursday, September 7th.
Read our dividend analysis for EXPO
.

Is Exponent a good dividend stock?

Exponent (NASDAQ:EXPO) pays an annual dividend of $1.04 per share and currently has a dividend yield of 1.22%. The company has been increasing its dividend for 5 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 52.79%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, EXPO will have a dividend payout ratio of 46.43% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for EXPO.

When did Exponent's stock split?

Exponent's stock split before market open on Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly minted shares were payable to shareholders after the market closes on Wednesday, June 6th 2018. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

What is Catherine Corrigan's approval rating as Exponent's CEO?

15 employees have rated Exponent Chief Executive Officer Catherine Corrigan on Glassdoor.com. Catherine Corrigan has an approval rating of 84% among the company's employees.

What other stocks do shareholders of Exponent own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Exponent investors own include AbbVie (ABBV), Pfizer (PFE), Abbott Laboratories (ABT), Energy Transfer (ET), Ford Motor (F), Micron Technology (MU), AT&T (T), UnitedHealth Group (UNH), Visa (V) and Adobe (ADBE).

What is Exponent's stock symbol?

Exponent trades on the NASDAQ under the ticker symbol "EXPO."

How do I buy shares of Exponent?

Shares of EXPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Exponent's stock price today?

One share of EXPO stock can currently be purchased for approximately $85.18.

How much money does Exponent make?

Exponent (NASDAQ:EXPO) has a market capitalization of $4.33 billion and generates $513.29 million in revenue each year. The business services provider earns $102.33 million in net income (profit) each year or $1.97 on an earnings per share basis.

How many employees does Exponent have?

The company employs 1,313 workers across the globe.

Does Exponent have any subsidiaries?
The following companies are subsidiares of Exponent: Dennis Publishing.
Read More
How can I contact Exponent?

Exponent's mailing address is 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025. The official website for the company is www.exponent.com. The business services provider can be reached via phone at (650) 326-9400, via email at investor-relations@exponent.com, or via fax at 650-326-8072.

This page (NASDAQ:EXPO) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -